Snippet from the article:
The good news is that new research in Japan, France and the US has moved closer to the goal of “curing” male baldness.
Dr George Cotsarelis, head of dermatology at the University of Pennsylvania, recently announced he was in talks with pharmaceutical companies about making a drug to block an enzyme he believes causes baldness. The enzyme, prostaglandin D2, was identified in a research paper in February as instructing follicles to stop the production of hair. But his laboratory is not the only one racing for a cure.
In June, Dr Bruno Bernard of L’OrÃ©al said he and his team had discovered that thinning hair is often due to follicles being in a “dormant” phase. It is all to do with the level of oxygen around stem cells called CD34+ cells. He thinks that by targeting these cells he can awaken them.
Meanwhile in Japan, a hairless mouse was given a stem-cell treatment to transplant hair follicles on its head from a hairy mouse. This breakthrough could mean that follicles might be grown in a lab and then transplanted on to the head.
Read the rest — A cure for baldness? It’s just a hair’s breadth away
There was a great focus on the work by Dr Cotsarelis and prostaglandin D2 at the recent 2012 ISHRS meeting. I’ll keep my fingers crossed that any of these new treatments (or “cures”) become a reality.